Gastrointestinal Cancer News

Before the opening of City of Hope’s new comprehensive cancer center, many residents of Orange County, California, faced a long commute for advanced cancer care.

Investigators have identified an elevated risk for hepatocellular carcinoma in people exposed to per- and polyfluoroalkyl substances, according to a study published in JHEP Reports.

Cristina R. Ferrone, MD, has been appointed chair of the department of surgery at Cedars-Sinai.

Loïc Le Marchand, MD, PhD, MPH, has been awarded the 2022 AACR Distinguished Lectureship on the Science of Cancer Health Disparities.

The FDA approved durvalumab with gemcitabine and cisplatin for adults with locally advanced or metastatic biliary tract cancer.

A risk-adapted approach for population-based colorectal cancer screening was a viable and cost-effective option compared with existing colonoscopy and fecal immunochemical test strategies, according to new research in China.

Adjuvant chemotherapy with modified FOLFIRINOX resulted in significantly longer survival vs. gemcitabine among patients with previously resected pancreatic ductal adenocarcinoma, according to 5-year data from a randomized phase 3 study.

High overall consumption of ultra-processed food appeared associated with a higher risk for colorectal cancer among men, but not women, according to study results published in The BMJ.

Despite increased perioperative risks in older patients with hepatocellular carcinoma and cirrhosis, orthotropic liver transplantation provides greater survival benefit compared with ablative therapies, according to new research.

Internally validated nomograms predicted the probability of early death and identified risk factors among patients with advanced hepatocellular carcinoma, according to research published in BMC Gastroenterology.